This past week, Dr. Glen Park, Sr. Director, Clinical and Regulatory Affairs presided at a very successful, highly interactive Pre-CTA meeting in Ottawa. The weather was beautiful and the view of the Ottawa River from the meeting room was breathtaking. The project is already ongoing in Israel, South Africa, and the US and will be shortly starting in Europe. Target Health is monitoring in the US and Canada, and performing 1) the global EDC trial, 2) data management, 3) biostatistics and 4) medical writing. We will also submit the NDA at the completion of the program.

For more information, please contact Dr. Jules T. Mitchel or Joyce Hays. For new business opportunities, contact Adrian Pencak, (Vice President, Business Development).

Comments

Leave a Reply

You must be logged in to post a comment.